Policy expert Paul Melmeyer breaks down what the current NIH funding decisions (in late Jan 2026) could mean for research momentum and patients.
All tagged Duchenne Muscular Dystrophy
Policy expert Paul Melmeyer breaks down what the current NIH funding decisions (in late Jan 2026) could mean for research momentum and patients.
When William was diagnosed with DMD, his family set out to raise $2.2 million to design a cure with CRISPR.
World-renowned geneticist, Madhuri Hegde, and Genetic counselor, Ann Martin discuss the genetics of Duchenne Muscular Dystrophy (DMD) and potential treatments.